ArticleWorld journal of clinical cases2021

Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report.

Xiao-Sheng Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.